Epizyme Announces Resignation Of President And CFO Jason Rhodes
September 02, 2014 at 16:31 PM EDT
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with ...